NCT07463651 2026-03-20
TROPHY-15
The First Affiliated Hospital of Soochow University
Phase 3 Recruiting
Clinical Trials
16 trialsNCT05468359 2026-03-16
Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
St. Jude Children's Research Hospital
Phase 1/2 Recruiting
NCT02559778 2026-02-20
PEDS-PLAN
Milton S. Hershey Medical Center
Phase 2 Recruiting
NCT05669339 2026-02-18
AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma
University of Florida
Phase 2 Recruiting
NCT02029001 2025-08-07
MOST plus
Centre Leon Berard
Phase 2 Recruiting
NCT05713994 2025-03-25
CCGLC-001
Tongji Hospital
Recruiting
NCT03899428 2025-03-24
Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCC
Humanity & Health Medical Group Limited
Phase 2 Recruiting
NCT05873244 2025-03-21
CXD101 in Immunotherapy-related Liver Cancer
Chinese University of Hong Kong
Phase 2 Recruiting
NCT06592989 2025-01-10
A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Recruiting
NCT06482086 2024-12-05
Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer
West China Hospital
Phase 2 Recruiting
NCT06690697 2024-11-15
Combination of Toripalimab and JS004 Therapy for ccRCC
Fudan University
Phase 2 Recruiting
NCT05594095 2024-10-04
SNF Platform Study of HR+/ HER2-advanced Breast Cancer
Fudan University
Phase 2 Recruiting
NCT06221683 2024-08-22
GMCAII
Children's Hospital of Soochow University
Phase 2 Recruiting
NCT06532084 2024-08-01
SoraGVL
St. Petersburg State Pavlov Medical University
Phase 2 Recruiting
NCT06527495 2024-07-30
Clinical Pharmacogenetic Study of Sorafenib in Egyptian Patients With Hepatocellular Carcinoma
Assiut University
Phase 1/2 Recruiting
NCT05717738 2024-06-13
CCGLC-008
Tongji Hospital
Recruiting